Search results
Iomab-B shows promise in high-risk leukemia treatment By Investing.com
Investing.com· 3 hours agoThe Phase 3 SIERRA trial data indicated that Iomab-B, a targeted radiotherapy, met its primary...
NRx Pharmaceuticals advances ketamine-based therapy By Investing.com
Investing.com· 3 hours agoNRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a clinical-stage biopharmaceutical company, is making...
New frontier for battery metals: Q&A with Craig Shesky, CFO of The Metals Company By Investing.com
Investing.com· 2 hours agoIn the rapidly evolving landscape of renewable energy, battery metals are becoming increasingly...
JPMorgan expects Walmart to overcome 2H24 uncertainties, upgrades shares rating By Investing.com
Investing.com· 2 hours agoOn Monday, JPMorgan (NYSE:JPM) has upgraded shares of Walmart Inc. (NYSE:WMT) from Neutral to...
Earnings call: J.Jill reports strong Q1 2024 results with strategic growth plans By Investing.com
Investing.com· 7 hours agoThe company's deliberate full-price selling strategy and a disciplined operating model have led to...
Conduent buys back all of shares owned by Carl Icahn, stock jumps By Investing.com
Investing.com· 2 hours agoBillionaire investor Carl Icahn has sold his approximately 18% stake in Conduent (NASDAQ:CNDT) back...
Morgan Stanley cuts Nestle rating to equal-weight on growth concerns By Investing.com
Investing.com· 2 hours agoOn Monday, Nestle SA (SIX:NESN:SW) (OTC: NSRGY (OTC:NSRGY)) experienced a shift in its stock outlook...
Roth/MKM sets fresh target on Bitdeer shares post-Desiweminer deal By Investing.com
Investing.com· 2 hours agoOn Monday, Roth/MKM maintained a positive stance on Bitdeer Technologies Group (NASDAQ: BTDR)...
UBS: iPhone purchase intent remains soft while interest in AI is muted By Investing.com
Investing.com· 1 hour agoDemand for Apple's (NASDAQ:AAPL) iPhone remains soft as interest in AI appears “muted,” analysts at...
Citizens & Northern director buys shares worth $1,869 By Investing.com
Investing.com· 2 hours agoIn a recent transaction, Katherine W. Shattuck, a director of CITIZENS & NORTHERN CORP...